|

Lenvatinib Capsules Clinical Trials

3 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Tianjin Medical University Second Hospital1
  • National Cancer Institute, Naples1
  • Asan Medical Center1

Indications

  • Cancer3
  • Precision Medicine1
  • Vulva Cancer1
  • GIST1
  • Solid Tumor1

Other3 trials

Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients
Phase 1/2
Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
Phase 2
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.